BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10503273)

  • 21. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
    Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
    BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece.
    Matsiota-Bernard P; Vrioni G; Marinis E
    J Clin Microbiol; 1998 Jan; 36(1):20-3. PubMed ID: 9431913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the line-probe assay for rapid detection of rifampicin-resistant Mycobacterium tuberculosis in Vietnam.
    Shah NS; Lan NT; Huyen MN; Laserson K; Iademarco MF; Binkin N; Wells C; Varma JK
    Int J Tuberc Lung Dis; 2009 Feb; 13(2):247-52. PubMed ID: 19146755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
    Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis.
    Viveiros M; Leandro C; Rodrigues L; Almeida J; Bettencourt R; Couto I; Carrilho L; Diogo J; Fonseca A; Lito L; Lopes J; Pacheco T; Pessanha M; Quirim J; Sancho L; Salfinger M; Amaral L
    J Clin Microbiol; 2005 Sep; 43(9):4880-4. PubMed ID: 16145166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):110-5. PubMed ID: 21276306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Geographical profile of rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis isolates in Sri Lanka.
    Adikaram CP; Perera J; Wijesundera SS
    Microb Drug Resist; 2012 Oct; 18(5):525-30. PubMed ID: 22731859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis.
    Mäkinen J; Marttila HJ; Marjamäki M; Viljanen MK; Soini H
    J Clin Microbiol; 2006 Feb; 44(2):350-2. PubMed ID: 16455882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?
    Schön T; Juréen P; Chryssanthou E; Giske CG; Kahlmeter G; Hoffner S; Angeby K
    J Antimicrob Chemother; 2013 Sep; 68(9):2074-7. PubMed ID: 23633684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis.
    Watterson SA; Wilson SM; Yates MD; Drobniewski FA
    J Clin Microbiol; 1998 Jul; 36(7):1969-73. PubMed ID: 9650946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular detection of rifabutin-susceptible Mycobacterium tuberculosis.
    Chen HY; Yu MC; Huang WL; Wu MH; Chang YL; Che CR; Jou R
    J Clin Microbiol; 2012 Jun; 50(6):2085-8. PubMed ID: 22442316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.
    Whitfield MG; Warren RM; Mathys V; Scott L; De Vos E; Stevens W; Streicher EM; Groenen G; Sirgel FA; Van Rie A
    J Antimicrob Chemother; 2018 Oct; 73(10):2667-2674. PubMed ID: 29982641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the rpoB macroarray assay to detect rifampin resistance in Mycobacterium tuberculosis in Beijing, China.
    Mokrousov I; Jiao WW; Sun GZ; Liu JW; Li M; Narvskaya O; Shen AD
    Eur J Clin Microbiol Infect Dis; 2006 Nov; 25(11):703-10. PubMed ID: 17061099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay.
    Cavusoglu C; Hilmioglu S; Guneri S; Bilgic A
    J Clin Microbiol; 2002 Dec; 40(12):4435-8. PubMed ID: 12454132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis.
    Zaw MT; Emran NA; Lin Z
    J Infect Public Health; 2018; 11(5):605-610. PubMed ID: 29706316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Impact of the
    Yu MC; Hung CS; Huang CK; Wang CH; Liang YC; Lin JC
    Microbiol Spectr; 2022 Aug; 10(4):e0075422. PubMed ID: 35924839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Line probe assay in the rapid detection of rifampin-resistant Mycobacterium tuberculosis directly from clinical specimens.
    Marttila HJ; Soini H; Vyshnevskaya E; Vyshnevskiy BI; Otten TF; Vasilyef AV; Viljanen MK
    Scand J Infect Dis; 1999; 31(3):269-73. PubMed ID: 10482056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of mutations in rpoB and codons 315 and 463 of katG in rifampin- and/or isoniazid-resistant Mycobacterium tuberculosis isolates from northeast Mexico.
    Viader-Salvadó JM; Luna-Aguirre CM; Reyes-Ruiz JM; Valdez-Leal R; del Bosque-Moncayo Mde L; Tijerina-Menchaca R; Guerrero-Olazarán M
    Microb Drug Resist; 2003; 9(1):33-8. PubMed ID: 12705681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.